首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Complementation in Cells Cotransfected with a Mixture of Wild-Type and Mutant Human Immunodeficiency Virus (HIV) Influences the Replication Capacities and Phenotypes of Mutant Variants in a Single-Cycle HIV Resistance Assay
【2h】

Complementation in Cells Cotransfected with a Mixture of Wild-Type and Mutant Human Immunodeficiency Virus (HIV) Influences the Replication Capacities and Phenotypes of Mutant Variants in a Single-Cycle HIV Resistance Assay

机译:在野生型和突变型人类免疫缺陷病毒(HIV)混合物共转染的细胞中的互补影响单周期HIV抗性测定中突变型变异体的复制能力和表型。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The impact of cotransfection of mixtures of mutant and wild type (WT) virus on the observed phenotype and replication capacity (RC) in a single-cycle human immunodeficiency virus (HIV) phenotypic assay has been investigated by cotransfecting mutant HIV clones expressing the firefly luciferase expression gene with a WT clone expressing Renilla luciferase. Four mutant constructs with different genotypes displayed <1% RC when transfected alone. Cotransfection of as little as 9% of the WT clone resulted in an 18- to 33-fold increase in the RC of the mutant clones. In addition, the 50% inhibitory concentration (IC50) of lopinavir against seven mutant clones decreased by up to 97% after incremental cotransfection of 9 to 50% of the WT clone. The enhancement of RC and decrease in IC50 for mutant variants following cotransfection with the WT variant appear to be due to complementation rather than genetic recombination. These findings suggest that the RC and susceptibility of plasma isolates from patients who are off therapy or not adherent to treatment, in which WT virus may expand to significant levels, should be interpreted with caution.
机译:通过共转染表达萤火虫荧光素酶的突变HIV克隆,研究了在单周期人类免疫缺陷病毒(HIV)表型分析中突变和野生型(WT)病毒混合物共转染对观察到的表型和复制能力(RC)的影响。具有表达海肾荧光素酶的WT克隆的表达基因。单独转染时,具有不同基因型的四个突变体构建体显示<1%RC。低至9%的WT克隆的共转染导致突变克隆的RC增加18到33倍。此外,洛匹那韦对7个突变体克隆的50%抑制浓度(IC50)在WT克隆的9至50%的增量共转染后降低了多达97%。与WT变体共转染后,突变变体的RC增强和IC50降低似乎是由于互补而不是基因重组。这些发现表明,在未接受治疗或未坚持治疗的患者中分离株的RC和药敏性应谨慎解释,其中WT病毒可能会扩散至显着水平。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号